| Financial Year |
March 31 2023 |
| Monetary Funds |
369,599,759.42 |
| Held-for-trading Financial Assets |
549,816,781.32 |
| Notes Receivable |
34,819,346.69 |
| Accounts Receivable |
140,972,527.88 |
| Advances to Suppliers |
56,616,610.54 |
| Other Receivables |
38,199,938.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
514,276,592.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
13,285,366.78 |
| Other Current Assets |
26,396,027.00 |
| Total Current Assets |
1,747,868,653.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
49,684,749.42 |
| Investment Properties |
73,959,204.00 |
| Fixed Assetes |
1,383,433,487.87 |
| Under-construction Projects |
441,310,522.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
252,608,422.62 |
| R&D expenses |
306,603.77 |
| Goodwill |
3,521,187.95 |
| Long-Term Deferred and Prepaid Expenses |
72,489,254.04 |
| Deferred Income Tax Assets |
10,535,380.50 |
| Other Non-Current Assets |
167,608,640.66 |
| Sub-Total of Non-Current Assets |
2,767,775,428.74 |
| Total Assets |
4,515,644,082.28 |
| Short-Term Loans |
636,680,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
115,275,167.54 |
| Accounts Payable |
466,450,609.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,698,595.59 |
| Taxes Payable |
25,431,868.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
179,922,668.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,826,779.98 |
| Other Current Liabilities |
42,907,528.08 |
| Sub-Total of Current Liabilities |
1,800,257,494.84 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
39,419,322.26 |
| Other Non-Current Liabilities |
4,836,338.16 |
| Sub-Total of Non-Current Liabilities |
76,936,080.22 |
| Total Liabilities |
1,877,193,575.06 |
| Paid-In Capital(Or Share Stock) |
154,256,882.00 |
| Capital Surplus |
1,075,634,348.70 |
| Surplus Reserve |
77,191,332.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,225,960,267.37 |
| Minority Stockholder's Interest |
6,706,757.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,631,743,750.13 |
| Owner's Equity（Stockholder's Equity） |
2,638,450,507.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,515,644,082.28 |
